Results 91 to 100 of about 21,265 (190)

The Overexpression of Myelin and Lymphocyte Protein (MAL) Downregulates MUC1 and Enhances Cisplatin Sensitivity in Non-Small Cell Lung Cancer Cells. [PDF]

J Cancer
Saldaña-Villa AK, Vázquez-Almazán B, Flores-Maldonado C, Vizuet-de-Rueda JC, Oropeza-Durán EN, Bonilla-Delgado J, Cortés-Malagón EM, Contreras RG, Teran LM, Ortiz-Quintero B, Lara-Lemus R.   +10 more
europepmc   +1 more source

Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ramesh SS, Rogge M, Kim J, Kang S, Kidd K, Williams A, Roignot J, Blakeslee K, Bleyer AJ, Kim S.   +9 more
europepmc   +1 more source

MUC1 Antibody [PDF]

, 2020
openaire   +1 more source

Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer

Disease Models & Mechanisms
Lixin Zhang, Yusi Fang, Ibrahim Uygun, Danyang Li, Mary Strange, Syed K. Zaidi, Wenjia Wang, Julia Knight, Mackenzy Radolec, Esther Elishaev, Joan F. Brozick, Allison Edwards, George Tseng, Sandra Cascio, Ronald Buckanovich, Robert P. Edwards, Anda M. Vlad   +16 more
doaj   +1 more source

Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway. [PDF]

Bioact Mater
Zou B, Li S, Luk KH, Dong X, Chun-Him Lai N, Cheng WY, Liu G, Wong KH, Chen T.   +8 more
europepmc   +1 more source

Integrated single-cell and bulk transcriptomics reveals an IGF2BP3-driven metabolic circuitry in endometrial cancer. [PDF]

BMC Cancer
Jiang R, Lin X, Zheng J, Xie N, Li Y, Lin F, Wang S, Zhang R, Sun Y.   +8 more
europepmc   +1 more source

Progesterone resistance in atypical endometrial hyperplasia: Expression and mechanisms of hormone-responsive molecules. [PDF]

Medicine (Baltimore)
Huang Z, Jiang T, Yao J, Tian Z, Liang Z, Lin Z, Huang P.   +6 more
europepmc   +1 more source

MUC1 Positive [PDF]

, 2020
openaire   +1 more source

Trastuzumab Resistance, a Potential Roadblock for Most Successful Therapy of Breast Cancer-An Updated Review of Underlying Mechanisms, Clinical Trials and Patents to Evade the Resistance. [PDF]

Pharmaceutics
Hasan G, Pramanik S, Singh S, Gurav P, Penumaka SM, Kumar S, Mandal D.   +6 more
europepmc   +1 more source

GCNT3 and ST3GAL1 expression correlates with HER2 status and MUC1/β-catenin/Cyclin D1 axis in breast cancer. [PDF]

BMC Cancer
Gupta R, Gopalsamy IK, Nadukkandy AS, Singh A, Tangella CR, Alexander LE, Nair RA, Cordani M, Kumar LD.   +8 more
europepmc   +1 more source